業績

2017年度 :: 著書・雑誌 :: 英文 :: 原著 :: 業績

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a random- ized, open-label, phase III, noninferiority trial.

Yamada Y, Denda T, Gamoh M, Iwanaga I, Yuki S, Shimodaira H, Nakamura M, Yamaguchi T, Ohori H, Kobayashi K, Tsuda M, Kobayashi Y, Miyamoto Y, Kotake M, Shimada K, Sato A, Morita S, Takahashi S, Komatsu Y, Ishioka C.

Ann Oncol. 2018; 29(3): 524-531

Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemo- therapy against advanced hepatocellular carcinoma.

Tsunematsu S, Suda G, Yamasaki K, Kimura M, Takaaki I, Umemura M, Ito J, Sato F, Nakai M, Sho T, Morikawa K, Ogawa K, Kamiyama T, Taketomi A, Sakamoto N.

Hepatol Res. 2017; 47(6): 533-541

Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infection.

Tsukuda Y, Suda G, Tsunematsu S, Ito J, Sato F, Terashita K, Nakai M, Sho T, Maehara O, Shimazaki T, Kimura M, Morikawa K, Natsuizaka M, Ogawa K, Ohnishi S, Chuma M, Sakamoto N.

J Med Virol. 2017; 89(5): 857-866

Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.

Tsuda M, Asaka M, Kato M, Matsushima R, Fujimori K, Akino K, Kikuchi S, Lin Y, Sakamoto N.

Helicobacter. 2017; 22(5): e12415

Preliminary study of automatic gastric cancer risk classifica- tion from photofluorography.

Togo R, Ishihara K, Mabe K, Oizumi H, Ogawa T, Kato M, Sakamoto N, Nakajima S, Asaka M, Haseyama M.

World J Gastrointest Oncol. 2018; 10(2): 62-70

Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype1hepatitis C virus infection: A randomized controlled study.

Suda G, Ito J, Nagasaka A, Yamamoto Y, Furuya K, Okamoto M, Terashita K, Kobayashi T, Tsunematsu I, Yoshida J, Meguro T, Ohara M, Kawagishi N, Kimura M, Umemura M, Izumi T, Tsukuda Y, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N.

Hepatol Res. 2018; 48(3): E146-E154

Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment.

Suda G, Nagasaka A, Yamamoto Y, Furuya K, Kumagai K, Kudo M, Terashita K, Kobayashi T, Tsunematsu I, Yoshida J, Meguro T, Kimura M, Ito J, Umemura M, Izumi T, Tsunematsu S, Sato F, Tsukuda Y, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N.

Hepatol Res. 2017; 47(11): 1127-1136

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.

Suda G, Furusyo N, Toyoda H, Kawakami Y, Ikeda H, Suzuki M, Arataki K, Mori N, Tsuji K, Katamura Y, Takaguchi K, Ishikawa T, Tsuji K, Shimada N, Hiraoka A, Yamsaki S, Nakai M, Sho T, Morikawa K, Ogawa K, Kudo M, Nagasaka A, Furuya K, Yamamoto Y, Kato K, Ueno Y, Iio E, Tanaka Y, Kurosaki M, Kumada T, Chayama K, Sakamoto N.

J Gastroenterol. 2018; 53(1): 119-128

A phase I study of combination therapy with sorafenib and 5-fluorouracil in patients with advanced hepatocellular carci- noma.

Sho T, Nakanishi M, Morikawa K, Ohara M, Kawagishi N, Izumi T, Umemura M, Ito J, Nakai M, Suda G, Ogawa K, Chuma M, Meguro T, Nakamura M, Nagasaka A, Horimoto H, Yamamoto Y, Sakamoto N.

Drugs R D. 2017; 17(3): 381-388

Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive C

Shinozaki E, Yoshino T, Yamazaki K, Muro K, Yamaguchi K, Nishina T, Yuki S, Shitara K, Bando H, Mimaki S, Nakai C, Matsushima K, Suzuki Y, Akagi K, Yamanaka T, Nomura S, Fujii S, Esumi H, Sugiyama M, Nishida N, Mizokami M, Koh Y, Abe Y, Ohtsu A, Tsuchihara K.

Br J Cancer. 2017; 117(10): 1450-1458

Conditioned medium obtained from amnion-derived mesenchymal stem cell culture prevents activation of keloid fibroblasts.

Sato C, Yamamoto Y, Funayama E, Furukawa H, Oyama A, Murao N, Hosono H, Kawakubo K, Sakamoto N, Ohnishi S.

Plast Reconstr Surg. 2018; 141(2): 390-398

Usefulness of detection of clarithromycin-resistant Helico- bacter pylori from fecal specimens for young adults treated with eradication therapy.

Osaki T, Mabe K, Zaman C, Yonezawa H, Okuda M, Amagai K, Fujieda S, Goto M, Shibata W, Kato M, Kamiya S.

Helicobacter. 2017; 22(5)

Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromy- cin and metronidazole in patients allergic to penicillin.

Ono S, Kato M, Nakagawa S, Mabe K, Sakamoto N.

Helicobacter. 2017; 22(3)

Rapid urine antibody test for Helicobacter pylori infection in adolescents.

Okuda M, Mabe K, Lin Y, Chaochen W, Taniguchi Y, Kato M, Kikuchi S.

Pediatr Int. 2017; 59(7): 798-802

Enrichment of Helicobacter pylori mutant strains after eradi- cation therapy analyzed by gastric wash-based quantitative pyrosequencing.

Oikawa R, Watanabe Y, Miyamoto S, Sato Y, Ono S, Mabe K, Yamamoto H, Kato M, Itoh F.

Tumour Biol. 2017; 39(10): 1010428317734865

Additive effect of rikkunshito, an herbal medicine, on chemo- therapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02).

Ohnishi S, Watari H, Kanno M, Ohba Y, Takeuchi S, Miyaji T, Oyamada S, Nomura E, Kato H, Sugiyama T, Asaka M, Sakuragi N, Yamaguchi T, Uezono Y, Iwase S.

J Gynecol Oncol. 2017; 28(5): e44

Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma.

Natsuizaka M, Whelan KA, Kagawa S, Tanaka K, Giroux V, Chandramouleeswaran PM, Long A, Sahu V, Darling DS, Que J, Yang Y, Katz JP, Wileyto EP, Basu D, Kita Y, Natsugoe S, Naganuma S, Klein-Szanto AJ, Diehl JA, Bass AJ, Wong KK, Rustgi AK, Nakagawa H.

Nat Commun. 2017; 8(1): 1758

Evaluation of an e-learning system for diagnosis of gastric lesions using magnifying narrow-band imaging: a multicenter randomized controlled study.

Nakanishi H, Doyama H, Ishikawa H, Uedo N, Gotoda T, Kato M, Nagao S, Nagami Y, Aoyagi H, Imagawa A, Kodaira J, Mitsui S, Kobayashi N, Muto M, Takatori H, Abe T, Tsujii M, Watari J, Ishiyama S, Oda I, Ono H, Kaneko K, Yokoi C, Ueo T, Uchita K, Matsumoto K, Kanesaka T, Morita Y, Katsuki S, Nishikawa J, Inamura K, Kinjo T, Yamamoto K, Yoshimura D, Araki H, Kashida H, Hosokawa A, Mori H, Yamashita H, Motohashi O, Kobayashi K, Hirayama M, Kobayashi H, Endo M, Yamano H, Murakami K, Koike T, Hirasawa K, Miyaoka Y, Hamamoto H, Hikichi T, Hanabata N, Shimoda R, Hori S, Sato T, Kodashima S, Okada H, Mannami T, Yamamoto S, Niwa Y, Yashima K, Tanabe S, Satoh H, Sasaki F, Yamazato T, Ikeda Y, Nishisaki H, Nakagawa M, Matsuda A, Tamura F, Nishiyama H, Arita K, Kawasaki K, Hoppo K, Oka M, Ishihara S, Mukasa M, Minamino H, Yao K.

Endoscopy. 2017; 49(10): 957-967

A prospective observational study on effect of short-term periodic steroid premedication on bone metabolism in gas- trointestinal cancer (ESPRESSO-01).

Nakamura M, Ishiguro A, Muranaka T, Fukushima H, Yuki S, Ono K, Murai T, Matsuda C, Oba A, Itaya K, Sone T, Yagisawa M, Koike Y, Endo A, Tsukuda Y, Ono Y, Kudo T, Nagasaka A, Nishikawa S, Komatsu Y.

Oncologist. 2017; 22(5): 592-600

Increased serum C-reactive protein and decreased urinary aquaporin2levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis.

Nakai M, Ogawa K, Takeda R, Ohara M, Kawagishi N, Izumi T, Umemura M, Ito J, Sho T, Suda G, Morikawa K, Sakamoto N.

Hepatol Res. 2017; 48(3): E311-E319

Accuracy of CT colonography for detection of polypoid and nonpolypoid neoplasia by gastroenterologists and radiolo- gists: A nationwide multicenter study in Japan.

Nagata K, Endo S, Honda T, Yasuda T, Hirayama M, Takahashi S, Kato T, Horita S, Furuya K, Kasai K, Matsumoto H, Kimura Y, Utano K, Sugimoto H, Kato H, Yamada R, Yamamichi J, Shimamoto T, Ryu Y, Matsui O, Kondo H, Doi A, Abe T, Yamano H, Takeuchi K, Hanai H, Saida Y, Fukuda K, N?ppi J, Yoshida H.

Am J Gastroenterol. 2017; 112(1): 163-171

Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer.

Muranaka T, Kuwatani M, Komatsu Y, Sawada K, Nakatsumi H, Kawamoto Y, Yuki S, Kubota Y, Kubo K, Kawahata S, Kawakubo K, Kawakami H, Sakamoto N.

J Gastrointest Oncol. 2017; 8(3): 566-571

Oral administration of conditioned medium obtained from mesenchymal stem cell culture prevents subsequent stric- ture formation after esophageal submucosal dissection in pigs.

Mizushima T, Ohnishi S, Hosono H, Yamahara K, Tsuda M, Shimizu Y, Kato M, Asaka M, Sakamoto N.

Gastrointest Endosc. 2017; 86(3): 542-552

Endoscopic ultrasonography features of gastric mucosal cobblestone-like changes from a proton-pump inhibitor.

Miyamoto S, Kudo T, Kato M, Matsuda K, Abiko S, Tsuda M, Mizushima T, Yamamoto K, Ono S, Shimizu Y, Sakamoto N.

Clin J Gastroenterol. 2017; 10(3): 220-223

Gastric mucosal cracked and cobblestone-like changes resulting from proton pump inhibitor use.

Miyamoto S, Kato M, Tsuda M, Matsuda K, Muranaka T, Abiko S, Ono M, Mizushima T, Omori S, Yamamoto K, Mabe K, Ono S, Kudo T, Shimizu Y, Sakamoto N.

Dig Endosc. 2017; 29(3): 307-313

Gastric hyperplastic polyps associated with proton pump inhibitor use in a case without a history of helicobacter pylori infection.

Miyamoto S, Kato M, Matsuda K, Abiko S, Tsuda M, Mizushima T, Yamamoto K, Ono S, Kudo T, Shimizu Y, Hatanaka KC, Tsunematsu I, Sakamoto N.

Intern Med. 2017; 56(14): 1825-1829

Safety of cold polypectomy for colorectal polyps in patients on antithrombotic medication.

Matsumoto M, Yoshii S, Shigesawa T, Dazai M, Onodera M, Kato M, Sakamoto N.

Digestion. 2018; 97(1): 76-81

Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esopha- geal squamous cell carcinoma.

Maehara O, Suda G, Natsuizaka M, Ohnishi S, Komatsu Y, Sato F, Nakai M, Sho T, Morikawa K, Ogawa K, Shimazaki T, Kimura M, Asano A, Fujimoto Y, Ohashi S, Kagawa S, Kinugasa H, Naganuma S, Whelan KA, Nakagawa H, Nakagawa K, Takeda H, Sakamoto N.

Carcinogenesis. 2017; 38(11): 1073-1083

First progress report on the Japan Endoscopy Database (JED) project.

Kodashima S, Tanaka K, Matsuda K, Fujishiro M, Saito Y, Ohtsuka K, Oda I, Katada C, Kato M, Kida M, Kobayashi K, Hoteya S, Horimatsu T, Matsuda T, Muto M, Yamamoto H, Ryozawa S, Iwakiri R, Kutsumi H, Miyata H, Kato M, Haruma K, Fujimoto K, Uemura N, Kaminishi M, Tajiri H.

Dig Endosc. 2018; 30(1): 20-28

Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based thera- pies for hepatitis C.

Kawagishi N, Suda G, Onozawa M, Kimura M, Maehara O, Ohara M, Izumi T, Umemura M, Ito J, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, akamoto N.

J Viral Hepat. 2017; 24(12): 1098-1106

Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection.

Kawagishi N, Suda G, Onozawa M, Kimura M, Maehara O, Ito J, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N.

J Hepatol. 2017; 67(5): 1106-1108

Predictors for bile duct stone recurrence after endoscopic extraction for na?ve major duodenal papilla: A cohort study.

Kato S, Chinen K, Shinoura S, Kikuchi K.

PLoS One. 2017; 12(7): e0180536

Image assessment of Barrett's esophagus using the simplified narrow band imaging classification.

Kato M, Goda K, Shimizu Y, Dobashi A, Takahashi M, Ikegami M, Shimoda T, Kato M, Sharma P.

J Gastroenterol. 2017; 52(4): 466-475

Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population.

Ishihara R, Oyama T, Abe S, Takahashi H, Ono H, Fujisaki J, Kaise M, Goda K, Kawada K, Koike T, Takeuchi M, Matsuda R, Hirasawa D, Yamada M, odaira J, Tanaka M, Omae M, Matsui A, Kanesaka T, Takahashi A, Hirooka S, Saito M, Tsuji Y, Maeda Y, Yamashita H, Oda I, Tomita Y, Matsunaga T, Terai S, Ozawa S, Kawano T, Seto Y.

J Gastroenterol. 2017; 52(7): 800-808

Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan.

Funakoshi T, Horimatsu T, Nakamura M, Shiroshita K, Suyama K, Mukoyama M, Mizukami T, Sakurada T, Baba E, Tsuruya K, Nozaki A, Yahata K, Ozaki Y, Ubara Y, Yasui H, Yoshimoto A, Fukuma S, Kondo N, Matsubara T, Matsubara K, Fukuhara S, Yanagita M, Muto M.

ESMO Open. 2018; 3(2): e000301

Immunity against hepatitis B virus and HBV vaccines.

Doi H, Morikawa K, Kanto T.

eLS. 2018; 1-8

Magnifying blue laser imaging versus magnifying nar- row-band imaging for the diagnosis of early gastric cancer: A prospective, multicenter, omparative study.

Dohi O, Yagi N, Yoshida S, Ono S, Sanomura Y, Tanaka S, Naito Y, Kato M.

Digestion. 2017; 96(3): 127-134

>